• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Brought to you by:

Cell & Gene Therapy

Explore the latest news and insight around cell and gene therapy, including new technology and information on treatments in this growing field. See how pharma is leveraging gene therapy and cell therapy to prevent and treat disease.

Brought to you by:
0
denovirus transmission replication treatments 3D scientific illustration
Biotech

Biogen discontinues all AAV gene therapy work

While most of the team members that had focused on AAV capsids were reassigned to other roles, a small number of employees were laid off.
Gabrielle Masson Sep 26, 2025 11:04am
business targets illustration

uniQure plans FDA push after Huntington's gene therapy trial win

Sep 24, 2025 9:20am
life preserver

Carisma's lifeline disappears as reverse merger plans break down

Sep 18, 2025 10:40am
MRI image of a brain next to a model of DNA

VectorY pens $1.2B pact to use Shape's brain-penetrating capsid

Sep 18, 2025 9:25am
reducing people on team

ArsenalBio halves staff amid reorganization efforts

Sep 17, 2025 4:55pm
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Innate loses 30% of workforce in focus on 'highest-value assets'

Sep 17, 2025 5:16am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings